Hyperway Pharm
Chengdu · Founded 2019
About Hyperway Pharm
Hyperway Pharm is a pharmaceutical R&D and production enterprise with R&D as the core driving force. It adheres to the philosophy of “Hai Na Baichuan, Bocai, Changzhi, Good People, and Great Deeds”, and is committed to building a world-leading research and development platform for small molecule innovative drugs and high-end APIs. Research and development platform for research and development platforms and high-tech barriers. Its core founding team is a special high-end talent in Chengdu, Sichuan Province, and has many Fortune 500 companies such as Bayer, Johnson & Johnson, Sanofi and Merck, as well as “Kingming Kant”. Work experience of domestic well-known pharmaceutical companies such as “Hengrui”, “Yangzijiang”, “Hai Cisco”, “Smart Chemical” and “Bite Pharmaceutical”, with rich experience in international and domestic drug development and management, and led the team. It has successively developed a number of world-class innovative drugs (which have entered clinical trials) and a number of high-end high-end generic drugs
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $41.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2025)
- Website: http://hyperwaypharma.com/en/
Industries & Categories
Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/hyperway-pharm-24615 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.